Seborrheic keratosis Tx: FDA-approved Eskata is a first for this common condition.
| Published in: | Dermatology Times Vol. 39; no. 9; pp. 69 - 70 |
|---|---|
| Main Author: | |
| Format: | statistics Journal Article |
| Published: |
MJH Life Sciences
Sep2018
|
| Online Access: | View this record in EBSCOhost |